The debate about the funding of Herceptin: A case study of ‘countervailing powers’-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The debate about the funding of Herceptin: A case study of ‘countervailing powers’

Published:2012-12 Issue:12 Volume:75 Page:2353-2361
ISSN:0277-9536
Container-title:Social Science & Medicine
language:en
Short-container-title:Social Science & Medicine

Author:

Gabe Jonathan,Chamberlain Kerry,Norris Pauline,Dew Kevin,Madden Helen,Hodgetts Darrin

Funder

Health Research Council of New Zealand

Publisher

Elsevier BV

Subject

History and Philosophy of Science,Health (social science)

Reference69 articles.

1. Partial progress: governing the pharmaceutical industry and the NHS, 1948–2008;Abraham;Journal of Health Politics, Policy and Law,2009

2. The pharmaceutical industry, the state and the NHS;Abraham,2009

3. How much will Herceptin really cost?;Barrett;British Medical Journal,2006

4. The making of Herceptin, a revolutionary treatment for breast cancer;Bazell,1998

5. Herceptin petition sends strong message;BCAC press release,2007

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accessing diagnosis and treatment: The experience of cancer as wrangling with the system;SSM - Qualitative Research in Health;2024-06

2. UK national newspapers’ representation of cancer patients and their care during the early part of the COVID‐19 pandemic: Invoking and undermining solidarity?;Sociology of Health & Illness;2024-05-25

3. Scoping Review of International Experience of a Dedicated Fund to Support Patient Access to Cancer Drugs: Policy Implications for Thailand;International Journal of Health Policy and Management;2024-01-28

4. Values, Politics and Power Relations in the Development and Regulation of Vaccines;Vaccines in Society;2024

5. Citizens’ opinions and experiences related to costs and reimbursements for medications in times of retrenchment: cross-sectional population surveys in 2015 and 2017;International Journal for Equity in Health;2022-03-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3